A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients

European Journal of Cancer

Volumn 41, Issue 10, 2005, Pages 1409-1415

  Wárlám Rodenhuis, Carla C ^a   Koot, Veronica C M ^b   Van Der Luijt, Rob B ^a   Vasen, Hans F A ^a   Ausems, Margreet G E M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Department of Registration and Research   (Netherlands)

Author keywords

BRCA1 gene; BRCA2 gene; Breast cancer; Hereditary breast cancer; Hospital population; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC RISK; HEREDITY; HETEROZYGOTE; HOSPITAL PATIENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MASTECTOMY; ONCOGENE; OVARY CANCER; PREDICTION; PRIORITY JOURNAL; RELATIVE;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MUTATION; OVARIAN NEOPLASMS; PEDIGREE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION;

EID: 20444495597     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.02.030     Document Type: Article

References (28)

1. A. Contegiacomo, M. Pensabene, and I. Capuano An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer Ann Oncol 15 2004 726 732
2. S.A. Narod, D. Ford, and P. Devilee An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families Am J Hum Genet 56 1995 254 264
3. A.A. Langston, K.E. Malone, and J.D. Thompson BRCA1 mutations in a population-based sample of young women with breast cancer N Engl J Med 334 1996 137 142
4. M.C. Southey, A.A. Tesoriero, and C.R. Andersen BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer Br J Cancer 79 1999 34 39
5. J. Peto, N. Collins, and R. Barfoot Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer J Natl Cancer Inst 91 1999 943 949
6. K.E. Malone, J.R. Daling, and C. Neal Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases Cancer 88 2000 1393 1402
7. D. Ellis, J. Greenham, and S. Hodgson Low prevalence of germline BRCA1 mutations in early onset breast cancer without a family history J Med Genet 37 2000 792 794
8. N. Loman, O. Johannsson, and U. Kristoffersson Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer J Natl Cancer Inst 93 2001 1215 1223
9. S. De Sanjosé, M. Léoné, and V. Bérez Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population based study Int J Cancer 106 2003 588 593
10. H. Papelard, G.H. de Bock, and R. van Eijk Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients Br J Cancer 83 2000 719 724
11. K. Syrjäkoski, P. Vahteristo, and H. Eerola Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients J Natl Cancer Inst 92 2000 1529 1531
12. M.C. King, J.H. Marks, and J.B. Mandell Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 2003 643 646
13. D. Shattuck-Eidens, A. Oliphant, and M. McClure BRCA1 sequence analysis in women at high risk for susceptibility mutations Jama 278 1997 1242 1250
14. M.J. Ligtenberg, F.B. Hogervorst, and H.W. Willems Characteristics of small breast and ovarium cancer families with germline mutations in BRCA1 and BRCA2 Br J Cancer 79 1999 1475 1478
15. D. Stoppa-Lyonnet, P. Laurent-Puig, and L. Essioux BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institute Curie Breast Cancer Group Am J Hum Genet 60 5 1997 1021 1030
16. F.B. Hogervorst, R.S. Cornelis, and M. Bout Rapid detection of BRCA1 mutations by the protein truncation test Nat Genet 10 2 1995 208 212
17. A. Petrij-Bosch, T. Peelen, and M. van Vliet BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients Nat Genet 17 3 1997 341 345
18. R.B. Van der Luijt, P.H.A. van Zon, and R.P.M. Jansen De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer J Med Genet 38 2001 102 105
19. Collaborative Group on Hormonal Factors in Breast Cancer Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease Lancet 358 2001 1389 1399
20. T.S. Frank, S.A. Manley, and O.I. Olopade Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk J Clin Oncol 16 1998 2417 2425
21. H.A. Shih, F.J. Couch, and K.L. Nathanson BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic J Cin Oncol 20 4 2002 994 999
22. R.A. Goldschmidt, and T.A. Victor Lobular carcinoma in situ of the breast Semin Surg Oncol 12 1996 314 320
23. E.R. Frykberg Lobular carcinoma in situ of the breast Breast J 5 1999 296 303
24. Breast Cancer Linkage Consortium Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases Lancet 349 1997 1505 1510
25. E.J. Meijers-Heijboer, L.C. Verhoog, and C.T.M. Brekelmans Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation Lancet 335 2000 2015 2020
26. L.C. Verhoog, C.T.M. Brekelmans, and C. Seynaeve Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer Br J Cancer 83 2000 384 386
27. B.G. Haffty, E. Harrold, and A.J. Khan Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status Lancet 359 2002 1471 1477
28. D. Schrag, K.M. Kuntz, and J.E. Garber Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations JAMA 283 2000 617 624